Suppr超能文献

[同量异位标签用于肝细胞癌蛋白质组学相对和绝对定量分析的研究进展]

[Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma].

作者信息

Qi Y Z, Chen L S, Xu P

机构信息

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China; State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning 530005, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2016 Dec 20;24(12):952-955. doi: 10.3760/cma.j.issn.1007-3418.2016.12.018.

Abstract

Due to the features of strong heterogeneity, difficult early diagnosis, poor prognosis, and high fatality rate, hepatocellular carcinoma (HCC) has become an important disease which threatens the health of the Chinese population. Accurate early diagnosis is crucial to improving the success rate of liver cancer resection and reducing postoperative recurrence and metastasis, and its core is the screening and validation of biomarkers for early diagnosis. Isobaric tags for relative and absolute quantitation (iTRAQ) and stable isotope labeling with amino acids in cell culture are important parts of proteomics technology, and iTRAQ has become the most important technique in quantitative proteomics technology due to its advantages of high throughput, high quantitative accuracy, and no limitation by sample source. This article reviews the research advances in molecular mechanism of the development and progression of HCC and screening of markers, in order to establish a theoretical foundation for in-depth understanding of the molecular mechanisms of the development and progression of HCC and the development of new biomarkers.

摘要

由于具有高度异质性、早期诊断困难、预后差和死亡率高等特点,肝细胞癌(HCC)已成为威胁中国人群健康的重要疾病。准确的早期诊断对于提高肝癌切除成功率、降低术后复发和转移至关重要,其核心是早期诊断生物标志物的筛选和验证。相对和绝对定量等压标签(iTRAQ)以及细胞培养中氨基酸的稳定同位素标记是蛋白质组学技术的重要组成部分,并且iTRAQ因其高通量、高定量准确性以及不受样品来源限制等优点,已成为定量蛋白质组学技术中最重要的技术。本文综述了HCC发生发展的分子机制及标志物筛选的研究进展,以期为深入了解HCC发生发展的分子机制及新型生物标志物的开发奠定理论基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验